Holen Sie sich die Stockscreener-App
8.07
2.70%
-0.28
Cvrx Inc Aktie (CVRX) Neueste Nachrichten
CVRx Inc. Stock Analysis and ForecastHigh-octane gains - Jammu Links News
CVRx shares rise on CMS inclusion for Barostim implant procedure - MSN
Is CVRx Inc. a good long term investmentFree Real-Time Stock Data - Jammu Links News
What risks could impact CVRX stock performanceFree Discussion Group - Newser
CVRx (CVRX) Surges 19.0%: Is This an Indication of Further Gains? - Yahoo Finance
CVRx announces Medicare win for Barostim therapy - MassDevice
CVRx's Barostim Gains Traction as CMS Reimbursement Policies Shift Gears - AInvest
What makes CVRX stock price move sharplySecure Your Capital Strategy - Newser
CVRx Soars 20% Amid Regulatory Reimbursement Breakthrough – What's Next for This Medtech Innovator? - AInvest
CVRx Announces Positive News on Outpatient Payment for Barostim - GlobeNewswire
$CVRX stock is up 15% today. Here's what we see in our data. - Quiver Quantitative
How CVRX stock performs during market volatilityFree Top-Rated Stock Analysis - Newser
CVRx, Inc. Announces Positive News on Outpatient Payment for Barostim - MarketScreener
Medicare proposes to maintain payment for CVRx’s Barostim procedure - Investing.com
CVRx Secures Triple Medicare Payment Victory for Barostim: $45K Outpatient Coverage Confirmed - Stock Titan
Why CVRx Inc. stock attracts strong analyst attentionFree Wealth-Building Investment Strategies - Newser
How CVRx Inc. stock performs during market volatilityShort Squeeze Radar - Newser
When TFINP stock expected to show significant growthIs CVRX stock a good long term investment optionFree Elite Traders Group - Newser
What makes CVRx Inc. stock price move sharplyFree VIP Investment Strategies - Newser
Why CVRX stock attracts strong analyst attentionDaily Breakout Picks - Newser
CVRx, Inc.'s (NASDAQ:CVRX) P/S Is Still On The Mark Following 25% Share Price Bounce - simplywall.st
CVRx, Inc. (NASDAQ:CVRX) institutional owners may be pleased with recent gains after 24% loss over the past year - simplywall.st
Long Term Trading Analysis for (CVRX) - news.stocktradersdaily.com
Analysts Are Bullish on These Healthcare Stocks: Evaxion Biotech (EVAX), CVRx (CVRX) - The Globe and Mail
Healthcare Stocks to Watch: Evaxion Biotech, CVRx, and Rockwell Medical Receive Bullish Sentiments - AInvest
Q2 Earnings Estimate for CVRx Issued By William Blair - Defense World
CVRx (NASDAQ:CVRX) Upgraded at William Blair - Defense World
William Blair Reaffirms Their Buy Rating on CVRx (CVRX) - The Globe and Mail
(CVRX) Trading Signals - news.stocktradersdaily.com
Fear And Fundamentals: Why CVRx Stock’s Sell-Off Ignores Its True Potential (NASDAQ:CVRX) - Seeking Alpha
CVRx, Inc. (NASDAQ:CVRX) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Rhumbline Advisers Buys 2,192 Shares of CVRx, Inc. (NASDAQ:CVRX) - Defense World
(CVRX) Technical Data - news.stocktradersdaily.com
Is CVRx (NASDAQ:CVRX) Weighed On By Its Debt Load? - simplywall.st
How to Take Advantage of moves in (CVRX) - news.stocktradersdaily.com
CVRx downgraded at J.P. Morgan after Q1 sales miss - MSN
Cantor Fitzgerald Comments on CVRx FY2026 Earnings - Defense World
Squarepoint Ops LLC Sells 8,855 Shares of CVRx, Inc. (NASDAQ:CVRX) - Defense World
Two Sigma Investments LP Has $702,000 Holdings in CVRx, Inc. (NASDAQ:CVRX) - Defense World
Top NASDAQ Stocks Kalkine CVRx, Inc. Amid Short Interest Shift - Kalkine Media
Jane Street Group LLC Sells 2,456 Shares of CVRx, Inc. (NASDAQ:CVRX) - Defense World
CVRx, Inc. (NASDAQ:CVRX) Shares Purchased by Bank of America Corp DE - Defense World
Short Interest in CVRx, Inc. (NASDAQ:CVRX) Increases By 19.4% - Defense World
CVRx, Inc. (NASDAQ:CVRX) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
CVRx Confirms Directors and Accounting Firm at Meeting - TipRanks
CVRx at William Blair Conference: Strategic Focus on Barostim - Investing.com
CVRx at William Blair Conference: Strategic Focus on Barostim By Investing.com - Investing.com India
0.52%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):